Literature DB >> 30909018

Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017.

Raminta Daniulaityte1, Matthew P Juhascik2, Kraig E Strayer3, Ioana E Sizemore3, Mussa Zatreh4, Ramzi W Nahhas5, Kent E Harshbarger2, Heather M Antonides2, Silvia S Martins6, Robert G Carlson4.   

Abstract

INTRODUCTION: There is a lack of information on illicitly manufactured fentanyl and fentanyl analogue-related (IMF) unintentional overdose death trends over time. The study analyzes IMF-related unintentional overdose fatalities that occurred between July 2015 and June 2017 in Montgomery County, Ohio, an area with the highest rates of unintentional overdose mortality in Ohio.
METHODS: LC-MS/MS-based method was used to identify fentanyl analogs and metabolites in 724 unintentional overdose death cases. The Chi-square statistic was used to assess differences over time in demographic and drug-related characteristics.
RESULTS: The number of unintentional overdose death cases testing positive for IMFs increased by 377% between second half of 2015 and first half of 2017. The majority of decedents were white (82.5%) and male (67.8%). The proportion of fentanyl-only (no other analogs) cases declined from 89.2%-24.6% (p < 0.001), while proportion of fentanyl analogue-containing cases increased from 9.8%-70.3% (p < 0.001) between the second half of 2015 and first half of 2017. The most commonly identified fentanyl analogs were carfentanil (29.7%), furanyl fentanyl (14.1%) and acryl fentanyl (10.2%). Proportion of IMF cases also testing positive for heroin declined from 21.6% to 5.4% (p < 0.001), while methamphetamine positive cases increased from 1.4%-17.8% (p < 0.001) over the same time period. DISCUSSION: Emergence of fentanyl analogs contributed to substantial increases in unintentional overdose deaths. The data indicate a growing overlap between the IMF and methamphetamine outbreaks. Continuous monitoring of local IMF trends and rapid information dissemination to active users are needed to reduce the risks associated with IMF use.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carfentanil; Fentanyl; Fentanyl analogs; Illicitly manufactured fentanyl; Ohio; Unintentional overdose deaths

Mesh:

Substances:

Year:  2019        PMID: 30909018      PMCID: PMC9419823          DOI: 10.1016/j.drugalcdep.2019.01.045

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.852


  24 in total

1.  Fentanyl in the US heroin supply: A rapidly changing risk environment.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-20

2.  Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Drug Alcohol Depend       Date:  2017-05-30       Impact factor: 4.492

3.  Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016.

Authors:  Christopher M Jones; Emily B Einstein; Wilson M Compton
Journal:  JAMA       Date:  2018-05-01       Impact factor: 56.272

4.  Understanding subtypes of inner-city drug users with a latent class approach.

Authors:  S J Kuramoto; A S B Bohnert; C A Latkin
Journal:  Drug Alcohol Depend       Date:  2011-04-29       Impact factor: 4.492

5.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

6.  Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016.

Authors:  Salman A Klar; Elizabeth Brodkin; Erin Gibson; Shovita Padhi; Christine Predy; Corey Green; Victoria Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-09-23       Impact factor: 17.586

7.  Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016.

Authors:  Anthony J Tomassoni; Kathryn F Hawk; Karen Jubanyik; Daniel P Nogee; Thomas Durant; Kara L Lynch; Rushaben Patel; David Dinh; Andrew Ulrich; Gail D'Onofrio
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

8.  Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016.

Authors:  Julie K O'Donnell; John Halpin; Christine L Mattson; Bruce A Goldberger; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-03       Impact factor: 17.586

9.  Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.

Authors:  Nicholas J Somerville; Julie O'Donnell; R Matthew Gladden; Jon E Zibbell; Traci C Green; Morgan Younkin; Sarah Ruiz; Hermik Babakhanlou-Chase; Miranda Chan; Barry P Callis; Janet Kuramoto-Crawford; Henry M Nields; Alexander Y Walley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-14       Impact factor: 17.586

10.  Overdose Deaths Related to Fentanyl and Its Analogs - Ohio, January-February 2017.

Authors:  Raminta Daniulaityte; Matthew P Juhascik; Kraig E Strayer; Ioana E Sizemore; Kent E Harshbarger; Heather M Antonides; Robert R Carlson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-01       Impact factor: 17.586

View more
  11 in total

1.  Toward the Interpretation of Positive Testing for Fentanyl and Its Analogs in Real Hair Samples: Preliminary Considerations.

Authors:  A Salomone; R Bigiarini; J J Palamar; C McKnight; L Vinsick; E Amante; D Di Corcia; M Vincenti
Journal:  J Anal Toxicol       Date:  2020-05-18       Impact factor: 3.367

2.  Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.

Authors:  Raminta Daniulaityte; Robert R Carlson; Matthew P Juhascik; Kraig E Strayer; Ioana E Sizemore
Journal:  Int J Drug Policy       Date:  2019-05-27

Review 3.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

4.  Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.

Authors:  Raminta Daniulaityte; Ramzi W Nahhas; Sydney Silverstein; Silvia Martins; Angela Zaragoza; Avery Moeller; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2019-09-22       Impact factor: 4.492

5.  Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender.

Authors:  Morgan M Philbin; Emily R Greene; Silvia S Martins; Natalie J LaBossier; Pia M Mauro
Journal:  Am J Prev Med       Date:  2020-09-24       Impact factor: 5.043

6.  Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket.

Authors:  Francois R Lamy; Raminta Daniulaityte; Monica J Barratt; Usha Lokala; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

7.  Improvements in Toxicology Testing to Identify Fentanyl Analogs and Other Novel Synthetic Opioids in Fatal Drug Overdoses, Connecticut, January 2016-June 2019.

Authors:  Heather A Clinton; Shobha Thangada; James R Gill; Amy Mirizzi; Susan B Logan
Journal:  Public Health Rep       Date:  2021 Nov-Dec       Impact factor: 2.792

8.  Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?

Authors:  Robert G Carlson; Raminta Daniulaityte; Sydney M Silverstein; Ramzi W Nahhas; Silvia S Martins
Journal:  Int J Drug Policy       Date:  2020-04-17

9.  Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS/MS and its application to authentic cases.

Authors:  Nan Qin; Min Shen; Ping Xiang; Di Wen; Baohua Shen; Hongxiao Deng; Huosheng Qiang; Fenyun Song; Yan Shi
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

Review 10.  Opioid epidemic and liver disease.

Authors:  Elizabeth C Verna; Aaron Schluger; Robert S Brown
Journal:  JHEP Rep       Date:  2019-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.